ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,192Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 609

$1.37M Total Retail Price of All Prescriptions

Rank: 7 out of 609

675 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,504 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
JANUVIA 931 738 10 1 34
METFORMIN HCL 730 583 2 10
LEVOTHYROXINE SODIUM 559 408 3 7
CRESTOR 496 386 4 16
SIMVASTATIN 409 312 5 1
ATORVASTATIN CALCIUM 402 354 6 6
ALENDRONATE SODIUM 368 343 7 54
METFORMIN HCL ER 342 273 8 115
AMLODIPINE BESYLATE 335 282 9 2
PEN NEEDLE 331 235 10 79
GLIMEPIRIDE 322 250 11 53
LANTUS SOLOSTAR 266 188 12 63
JANUMET 266 220 12 119
LOSARTAN POTASSIUM 247 195 14 24
CARVEDILOL 246 219 15 14
METOPROLOL SUCCINATE 244 229 16 5
LOVAZA 232 166 17 73
ACTOS 223 160 18 145
DIOVAN 185 153 19 15
INSULIN SYRINGE 175 153 20 140
LANTUS 159 130 21 82
ZETIA 154 103 22 89
FUROSEMIDE 147 118 23 4
ACARBOSE 141 124 24 226
GLIPIZIDE XL 141 133 24 234
DIOVAN HCT 140 133 26 31
LEVEMIR 129 113 27 280
NATEGLINIDE 128 98 28 172
RAMIPRIL 126 83 29 46
GABAPENTIN 125 105 30 21
TEKTURNA 122 105 31 368
PLAVIX 119 102 32 25
HYDROCHLOROTHIAZIDE 114 96 33 20
OMEPRAZOLE 105 95 34 3
LIPITOR 102 78 35 47
PRANDIN 102 99 35 181
LEVEMIR FLEXPEN 101 51 37 167
SYNTHROID 100 74 38 65
CLOPIDOGREL 99 83 39 17
LISINOPRIL 97 80 40 12
NEXIUM 94 80 41 13
WELCHOL 84 67 42 225
UNIFINE PENTIPS 83 70 43 248
GLIPIZIDE 81 55 44 169
EVISTA 80 54 45 207
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 48 46 77
NOVOLOG 76 69 46 156
TRICOR 75 51 48 130
NOVOLOG FLEXPEN 74 64 49 122
BYETTA 73 59 50 303
ZOLPIDEM TARTRATE 71 32 51 18
PRAVASTATIN SODIUM 71 64 51 35
GLYBURIDE-METFORMIN HCL 70 51 R 53 149
AMLODIPINE BESYLATE-BENAZEPRIL 69 60 54 88
ACTONEL 62 57 55 219
FENOFIBRATE 57 29 56 143
ENALAPRIL MALEATE 54 39 57 32
HUMALOG 52 32 58 117
METOPROLOL TARTRATE 50 33 59 9
VYTORIN 50 37 59 255
NOVOLOG MIX 70-30 FLEXPEN 50 49 59 274
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.